2017
DOI: 10.14740/jocmr3005w
|View full text |Cite
|
Sign up to set email alerts
|

Traumatic Abdominal Solid Organ Injury Patients Might Benefit From Thromboelastography-Guided Blood Component Therapy

Abstract: BackgroundThromboelastography (TEG) has been utilized for the guidance of blood component therapy (BCT). We aimed to investigate the association between emergent TEG-guided BCT and clinical outcomes in patients with traumatic abdominal solid organ (liver and/or spleen) injuries.MethodsA single center retrospective study of patients who sustained traumatic liver and/or spleen injuries receiving emergent BCT was conducted. TEG was ordered in all these patients. Patient demographics, general injury information, o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 26 publications
0
14
0
Order By: Relevance
“…Although CCTs patients needed a similar number of red blood cell units as TEG patients, patients in the CCTs group received more FFP and platelets units in the first 2 hours of resuscitation. 30 In the last study, Wang et al 37 reported a significant difference between the intervention and control groups for all the endpoints studied (red blood cells, 4±7 vs 9±10 units, P<0.01; platelets, 0.4±1.5 vs 2.9±4.8 units, P<0.01; FFP, 1±5 vs 5±6 units, P<0.01; ICU LOS 8.8±10.6 vs 13.6±14 days, P<0.05; hospital LOS 14±12 vs 19±1 days, P< 0.005).…”
Section: Resultsmentioning
confidence: 97%
See 1 more Smart Citation
“…Although CCTs patients needed a similar number of red blood cell units as TEG patients, patients in the CCTs group received more FFP and platelets units in the first 2 hours of resuscitation. 30 In the last study, Wang et al 37 reported a significant difference between the intervention and control groups for all the endpoints studied (red blood cells, 4±7 vs 9±10 units, P<0.01; platelets, 0.4±1.5 vs 2.9±4.8 units, P<0.01; FFP, 1±5 vs 5±6 units, P<0.01; ICU LOS 8.8±10.6 vs 13.6±14 days, P<0.05; hospital LOS 14±12 vs 19±1 days, P< 0.005).…”
Section: Resultsmentioning
confidence: 97%
“…The characteristics of the 6 studies are summarized in Table 1. [30][31][32][33]36,37 A random-effects model (DerSimonia-Laird method) or a fixed-effects model (Mantel-Haenszel method) were then applied when significant (I 2 ≥50% and P<0.1) or insignificant heterogeneity could be calculated. Heterogeneity was tested by estimating the proportion of between-study inconsistencies due to actual differences among studies rather than differences due to random error or chance, using the I 2 statistic.…”
Section: Methods Of Researchmentioning
confidence: 99%
“…These changes are likely dependent upon local practice as other studies have demonstrated increased blood product administration 133 ; however, standardization of thresholds 86,87 may alter these findings. Cost‐effectiveness 190 and shorter length of stay 191 have also been demonstrated.…”
Section: Resultsmentioning
confidence: 99%
“…2 ). Among the eight observational studies, seven were before-after comparisons [ 20 22 , 24 27 ], and one was a retrospective analysis [ 23 ]. The participants in these studies were all civilian trauma patients.…”
Section: Resultsmentioning
confidence: 99%
“… Data in studies of Cochrane [ 20 ], Campbell [ 21 ], and Wang [ 23 ] were expressed as mean ± standard deviation; data in studies of Mohamed [ 24 ] were expressed as mean; data in studies of Baksaas-Aasen [ 29 ], Unruh [ 22 ], Gonzalez [ 28 ], and Yin [ 25 ] were expressed as median (interquartile range). If there were data in several phases after injury, only the data in 24 h after admission/injury were recorded VHA viscoelastic hemostatic assay; TEG thrombelastography; ROTEM rotational thromboelastometry; MTP massive transfusion protocol; ISS injury severity score; RBCs red blood cells; MOI mechanism of injury; ITT: intent-to-treat *** P < 0.001 compared with VHA group, ** P < 0.01 compared with VHA group, * P < 0.05 compared with VHA group a fresh-frozen plasma/octaplasma b one pool = four individual platelet units c fibrinogen equivalent d cryoprecipitate e fibrinogen concentrate, –: not reported …”
Section: Resultsmentioning
confidence: 99%